Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (7): 583-587.doi: 10.35541/cjd.20220133
• Original Articles • Previous Articles Next Articles
Wang Lingyan, Pan Jing, Miao Gang, Chang Xiaodan, Jin Qiuzi, Guo Ningning, Zhang Jiayu
Received:
2022-03-02
Revised:
2022-06-21
Online:
2022-07-15
Published:
2022-07-05
Contact:
Pan Jing
E-mail:panjing32@139.com
Wang Lingyan, Pan Jing, Miao Gang, Chang Xiaodan, Jin Qiuzi, Guo Ningning, Zhang Jiayu. Analysis of difficult-to-treat sites in patients with psoriasis who received biological therapy[J]. Chinese Journal of Dermatology, 2022, 55(7): 583-587.doi:10.35541/cjd.20220133
[1] | Kivelevitch D, Frieder J, Watson I, et al. Pharmacotherapeutic approaches for treating psoriasis in difficult⁃to⁃treat areas[J]. Expert Opin Pharmacother, 2018,19(6):561⁃575. doi: 10.1080/14656566.2018.1448788. |
[2] | 中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国银屑病生物制剂治疗指南(2021)[J]. 中华皮肤科杂志, 2021,54(12):1033⁃1047. doi: 10.35541/cjd.20210643. |
[3] | Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus[J]. Arch Dermatol Res, 2011,303(1):1⁃10. doi: 10.1007/s00403⁃010⁃1080⁃1. |
[4] | Hjuler KF, Iversen L, Rasmussen MK, et al. Localization of treatment⁃resistant areas in patients with psoriasis on biologics[J]. Br J Dermatol, 2019,181(2):332⁃337. doi: 10.1111/bjd. 17689. |
[5] | Ibrahim GH, Buch MH, Lawson C, et al. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire[J]. Clin Exp Rheumatol, 2009,27(3):469⁃474. |
[6] | Takahashi MD, Chouela EN, Dorantes GL, et al. Efalizumab in the treatment of scalp, palmoplantar and nail psoriasis: results of a 24⁃week Latin American study[J]. Arch Drug Inf, 2010,3(1):1⁃8. doi: 10.1111/j.1753⁃5174.2009.00025.x. |
[7] | Rompoti N, Katsimbri P, Kokkalis G, et al. Real world data from the use of secukinumab in the treatment of moderate⁃to⁃severe psoriasis, including scalp and palmoplantar psoriasis: a 104⁃week clinical study[J]. Dermatol Ther, 2019,32(5):e13006. doi: 10.1111/dth.13006. |
[8] | Megna M, Cirillo T, Balato A, et al. Real⁃life effectiveness of biological drugs on psoriatic difficult⁃to⁃treat body regions: scalp, palmoplantar area and lower limbs[J]. J Eur Acad Dermatol Venereol, 2019,33(1):e22⁃e23. doi: 10.1111/jdv.15119. |
[9] | Cai L, Zhang JZ, Yao X, et al. Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis[J]. Chin Med J (Engl), 2020,133(22):2665⁃2673. doi: 10.1097/CM9.000000 0000001163. |
[10] | Ryan C, Sadlier M, De Vol E, et al. Genital psoriasis is associated with significant impairment in quality of life and sexual functioning[J]. J Am Acad Dermatol, 2015,72(6):978⁃983. doi: 10.1016/j.jaad.2015.02.1127. |
[11] | Suzuki T, Ito T, Gilhar A, et al. The hair follicle⁃psoriasis axis: shared regulatory mechanisms and therapeutic targets[J]. Exp Dermatol, 2022,31(3):266⁃279. doi: 10.1111/exd.14462. |
[12] | Lacarrubba F, Verzì AE, Musumeci ML, et al. High capillary diameter in psoriatic plaques of the lower legs[J]. Br J Dermatol, 2020,182(4):1064⁃1065. doi: 10.1111/bjd.18733. |
[13] | Muslimani MA, Bolcato V, de Silvestri A, et al. Psoriatic patients undergoing long⁃term therapy with biologics: impact of residual localization of psoriasis on quality of life in an Italian clinical setting[J]. Dermatol Ther, 2020,33(6):e14337. doi: 10.1111/dth.14337. |
[1] | Gao Zirui, Zhao Pei, Dou Yuanqing, Liu Ping, Zhang Jianzhong. Efficacy and safety of dupilumab in the treatment of adult prurigo nodularis [J]. Chinese Journal of Dermatology, 2022, 55(7): 562-565. |
[2] | Working Group for Atopic Dermatitis, Chinese Society of Dermatology, Working Group for Children′s Diseases, Chinese Society of Dermatology. Treatment of atopic dermatitis with dupilumab: an expert consensus [J]. Chinese Journal of Dermatology, 2022, 55(6): 465-470. |
[3] | Committee on Autoimmune Diseases, China Dermatologist Association. Cyclosporine in the treatment of immune-related skin diseases: an expert proposal [J]. Chinese Journal of Dermatology, 2022, 55(6): 471-479. |
[4] | Zhao Liuqi, Chen Yan, Chen Danyang, Fan Birao, Wang Rui, Shang Panpan, Chen Xixue, Zhu Xuejun, Wang Mingyue. Efficacy and safety of dupilumab in the treatment of 21 cases of bullous pemphigoid: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(6): 480-485. |
[5] | Huang Xin, Chen Xiaoyun, Li Yaping, Liang Xingkun, Zhang Guiying, Zhou Ying, Zhan Yi, Luo Shuaihantian, Liao Jieyue, Xiao Rong, Long Hai. Efficacy and safety of dupilumab in the treatment of 123 cases of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(6): 486-493. |
[6] | Shan Ying, Zuo Yagang. Correlation between autoimmune bullous diseases and psoriasis [J]. Chinese Journal of Dermatology, 2022, 55(5): 452-455. |
[7] | Luo Shuaihantian, Long Hai, Lu Qianjin, . Research advances in systemic lupus erythematosus in 2021 [J]. Chinese Journal of Dermatology, 2022, 55(4): 369-372. |
[8] | Liu Bo, Song Xiaoting, Li Ruoyu, Zhao Zuotao. Clinical efficacy and safety of dupilumab in the treatment of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 295-298. |
[9] | Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250. |
[10] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[11] | Wang Yue, Yan Yulin. Analysis of adverse drug reactions and reasons for drug discontinuation during acitretin therapy in 171 patients with psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2022, 55(3): 242-245. |
[12] | Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 55(3): 260-263. |
[13] | Wang Xiaowen, Li Ruoyu. Superficial fungal infections in psoriasis patients treated with IL-17 related biological agents and their management [J]. Chinese Journal of Dermatology, 2022, 55(3): 272-275. |
[14] | Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong. A comparative study of human immunoglobulin versus recombinant human tumor necrosis factor-α receptor Ⅱ:IgG Fc fusion protein in the treatment of toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2022, 55(2): 153-156. |
[15] | Zheng Jiayuan, Yu Bingqian, Chen Xianxia, Luo Zhicheng. Characteristics of pruritus in adult patients with psoriasis vulgaris and its effect on quality of life [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210153-e20210153. |
|